CSIMarket



Mylan N v   (MYL)
Other Ticker:  
 
 

MYL's Operating Income Growth by Quarter and Year

Mylan N V 's Operating Income results by quarter and year




MYL Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 391.80 232.80 1,024.60
III Quarter September 351.40 323.70 338.20 316.00
II Quarter June 134.20 - 178.90 227.20
I Quarter March 184.70 - 155.70 315.80
FY   670.30 715.50 905.60 1,883.60



MYL Operating Income third quarter 2020 Y/Y Growth Comment
Mylan N v achieved in the third quarter 2020, above Company average Operating Income improvement of 8.56% year on year, to $ 351.40 millions.

Looking into third quarter 2020 results within Major Pharmaceutical Preparations industry 24 other companies have achieved higher Operating Income growth. While Mylan N V ' s Operating Income increase of 8.56% ranks overall at the positon no. 1074 in the third quarter 2020.

Explain Operating Income growth


MYL Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - 68.3 % -77.28 % -
III Quarter September 8.56 % -4.29 % 7.03 % -23.1 %
II Quarter June - - -21.26 % 115.15 %
I Quarter March - - -50.7 % -25.5 %
FY   - -20.99 % -51.92 % 132.63 %

Financial Statements
Mylan N V 's third quarter 2020 Operating Income $ 351.40 millions MYL's Income Statement
Mylan N V 's third quarter 2019 Operating Income $ 323.70 millions Quarterly MYL's Income Statement
New: More MYL's historic Operating Income Growth >>


MYL Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 21.04 % -31.16 % 224.24 %
III Quarter September 161.85 % - 89.04 % 39.08 %
II Quarter June -27.34 % - 14.9 % -28.06 %
I Quarter March -52.86 % - -84.8 % -
FY (Year on Year)   - -20.99 % -51.92 % 132.63 %




Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #25
Healthcare Sector #105
Overall #1074

Operating Income Y/Y Growth Statistics
High Average Low
201.04 % 8.45 % -50.08 %
(March 31 2009)   (Sep. 30, 2009)
Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #25
Healthcare Sector #105
Overall #1074
Operating Income Y/Y Growth Statistics
High Average Low
201.04 % 8.45 % -50.08 %
(March 31 2009)   (Sep. 30, 2009)

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mylan N V 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
657.88 % 35.76 % -100 %
(Sep. 30, 2008)   (Mar 31 2019)


MYL's III. Quarter Q/Q Operating Income Comment
Mylan N v achieved in the III. Quarter 2020 above company average sequential Operating Income doubling of 161.85%, to $ 351.40 millions, from $134.20 millions in the second quarter.
Mylan N V is impressively improving, not only recording higher then regular growth, but also improving speed.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income quarter on quarter growth. While Mylan N V 's Operating Income growth quarter on quarter, overall rank is 270.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #24
Overall #270
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #24
Overall #270
Operating Income Q/Q Growth Statistics
High Average Low
657.88 % 35.76 % -100 %
(Sep. 30, 2008)   (Mar 31 2019)


MYL's III. Quarter Q/Q Operating Income Comment
Mylan N v achieved in the III. Quarter 2020 above company average sequential Operating Income doubling of 161.85%, to $ 351.40 millions, from $134.20 millions in the second quarter.
Major Pharmaceutical Preparations company is impressively improving, with reporting better then normal increase, and additionally accelerating pace, Archie  Wood, an industry consultant said.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income quarter on quarter growth. While Mylan N V 's Operating Income growth quarter on quarter, overall rank is 270.


Mylan N V 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Operating Income 12 Months Ending $ 1,062.10 $ 1,034.40 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) 2.68 % - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # 1075 # 1075 # 0 # 0 # 0




Cumulative Operating Income growth Comment
Although Mylan N V 's Annual Operating Income growth year on year were below company's average 22.43% , Operating Income announced in the Sep 30 2020 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 8.56% year on year, from % in Jun 30 2020. And, Mylan N V had the highest Operating Income growth, in Major Pharmaceutical Preparations industry.

Mylan N v achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
201.04 %
8.45 %
-50.08 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Operating Income TTM Y/Y Growth Statistics
High Average Low
145.65 %
22.43 %
-52.75 %
(Mar 31 2018)   (Mar 31 2019)


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 107
S&P 500 # 1075
Cumulative Operating Income growth Comment
Although Mylan N V 's Annual Operating Income growth year on year were below company's average 22.43% , Operating Income announced in the Sep 30 2020 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 8.56% year on year, from % in Jun 30 2020. And, Mylan N V had the highest Operating Income growth, in Major Pharmaceutical Preparations industry.

Mylan N v achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
201.04 %
8.45 %
-50.08 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Operating Income TTM Y/Y Growth Statistics
High Average Low
145.65 %
22.43 %
-52.75 %
(Mar 31 2018)   (Mar 31 2019)


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 107
S&P 500 # 1075




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
MYL's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for MYL's Competitors
Operating Income Growth for Mylan N V 's Suppliers
Operating Income Growth for MYL's Customers

You may also want to know
MYL's Annual Growth Rates MYL's Profitability Ratios MYL's Asset Turnover Ratio MYL's Dividend Growth
MYL's Roe MYL's Valuation Ratios MYL's Financial Strength Ratios MYL's Dividend Payout Ratio
MYL's Roa MYL's Inventory Turnover Ratio MYL's Growth Rates MYL's Dividend Comparisons



Companies with similar Operating Income doubling for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2020
Chemed Corporation14.45%$ 14.447 millions
Vericel Corporation13.56%$ 13.562 millions
Mettler Toledo International Inc12.33%$ 12.335 millions
Teleflex Incorporated12.30%$ 12.303 millions
Steris Plc11.47%$ 11.465 millions
Mylan N v 8.56%$ 8.557 millions
National Healthcare Corp6.91%$ 6.912 millions
Heska Corporation5.18%$ 5.181 millions
Prestige Consumer Healthcare Inc 5.13%$ 5.126 millions
Encompass Health Corporation4.58%$ 4.577 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LX's Profile

Stock Price

LX's Financials

Business Description

Fundamentals

Charts & Quotes

LX's News

Suppliers

LX's Competitors

Customers & Markets

Economic Indicators

LX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071